Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Asenapine, sold under the brand name Saphris among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder as well as the medium to long-term management of bipolar disorder.
The analysis highlights Applications and Standards as prominent areas in the source structure around Asenapine.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Asenapine shows recurring relationship patterns in the source. For example, Asenapine → D1, D2, D3, D4, Even, H1, H2, HT1A, HT1B, HT2A, HT2B, HT2C, HT5A, HT6, HT7 Another extracted example is Asenapine → AU: S4 (Prescription only), BR: Class C1 (Other controlled substances), EU: Rx-only, UK: POM (Prescription only), US: ℞-only. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
atypical acute schizophrenia disorder bipolar antipsychotic mania symptoms name significantly olanzapine receptors include found meta-analysis approved medication effects drug transdermal
TTTA extracted 70 structured relationships around Asenapine. Examples in this analysis include Asenapine → 3D model (JSmol) → Interactive image and Asenapine → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Asenapine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Asenapine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Asenapine | ATC code | N05AH05 (WHO) | 1.00 | infobox |
| Asenapine | Bioavailability | 35% (sublingual), <2% (oral), transdermal bioavailability is significantly higher than sublingual | 1.00 | infobox |
| Asenapine | CAS Number | 65576-45-6 N | 1.00 | infobox |
| Asenapine | CAS Number | as salt: 85650-56-2 | 1.00 | infobox |
| Asenapine | ChEBI | CHEBI:71253 N | 1.00 | infobox |
| Asenapine | ChEBI | as salt: CHEBI:71245 | 1.00 | infobox |
| Asenapine | ChEMBL | ChEMBL1201756 N | 1.00 | infobox |
| Asenapine | ChEMBL | as salt: ChEMBL2040684 | 1.00 | infobox |
| Asenapine | ChemSpider | 2300725 Y | 1.00 | infobox |
| Asenapine | ChemSpider | as salt: 5293095 | 1.00 | infobox |
| Asenapine | Drug class | Atypical antipsychotic | 1.00 | infobox |
| Asenapine | DrugBank | DB06216 | 1.00 | infobox |
| Asenapine | DrugBank | as salt: DBSALT000010 | 1.00 | infobox |
| Asenapine | ECHA InfoCard | 100.059.828 | 1.00 | infobox |
| Asenapine | Elimination half-life | 24 hours (sublingual), 30 hours (transdermal), 33.9 hours (transdermal) | 1.00 | infobox |
| Asenapine | Excretion | Kidney (50%), Fecal (40%; ~5–16% as unchanged drug in feces) | 1.00 | infobox |
| Asenapine | Formula | C17H16ClNO | 1.00 | infobox |
| Asenapine | IUPHAR/BPS | 22 | 1.00 | infobox |
| Asenapine | KEGG | D11769 | 1.00 | infobox |
| Asenapine | KEGG | as salt: D02995 | 1.00 | infobox |
| Asenapine | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Asenapine | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Asenapine | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Asenapine | Legal status | US: ℞-only | 1.00 | infobox |
| Asenapine | Legal status | EU: Rx-only | 1.00 | infobox |
| Asenapine | License data | EU EMA: by INN | 1.00 | infobox |
| Asenapine | License data | US DailyMed: Asenapine | 1.00 | infobox |
| Asenapine | License data | US FDA: Asenapine | 1.00 | infobox |
The concept neighborhoods around Asenapine bring nearby vocabulary together. In this analysis, examples include Disorder, Found and Atypical. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Asenapine, one of the stronger structural bridges in this analysis connects Asenapine with Adverse effects. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Asenapine to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications & Standards, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Asenapine · EN edition · Analysis: TopicsToTalkAbout
